rediff News http://www.rediff.com/tags/european+patent+office+total India's largest news and entertainment service online.. en-us Tue, 27 Sep 16 21:03:39 +0000 Tue, 27 Sep 16 21:03:39 +0000 http://www.rediff.com/push Rediff feeds Copyright: (C) 2009 Rediff.com India Limited. All Rights Reserved. <![CDATA[The desi genetic engineer and his fine crop of mustard]]> http://www.rediff.com/money/column/column-the-desi-genetic-engineer-and-his-fine-crop-of-mustard/20160921.htm Wed, 28 Sep 2016 02:33:39 +0530 <![CDATA[Markets end flat amid rangebound trade; Midcaps outperform]]> http://www.rediff.com/money/report/how-the-markets-fared-on-dec-29/20151229.htm Wed, 28 Sep 2016 02:33:39 +0530 <![CDATA[Markets finish higher for 5th straight session; oil, metals shine]]> http://www.rediff.com/money/report/how-the-markets-fared-on-oct-06/20151006.htm Wed, 28 Sep 2016 02:33:39 +0530 <![CDATA[Sensex ends above 29,000; SBI jumps 8%, M&M up 5%]]> http://www.rediff.com/money/report/how-the-markets-fared-on-feb-13/20150213.htm Wed, 28 Sep 2016 02:33:39 +0530 <![CDATA[Markets end higher; Sep inflation, RIL Q2 eyed]]> http://www.rediff.com/money/report/how-the-markets-fared-on-oct-13/20141013.htm Wed, 28 Sep 2016 02:33:39 +0530 <![CDATA[REI witnessed over 600 Exhibitors]]> http://www.energetica-india.net/news/rei-witnessed-over-600-exhibitors- Wed, 28 Sep 2016 02:33:39 +0530 <![CDATA[F-Secure Brings Total Security and Privacy to Consumers]]> http://in.sys-con.com/node/3921434 Wed, 28 Sep 2016 02:33:39 +0530 <![CDATA[Continuing Developments In Medical Consensus On The Utility Of Peppermint Oil For Irritable Bowel Syndrome (IBS)]]> http://in.advfn.com/news_Continuing-Developments-In-Medical-Consensus-On-Th_72532620.html Wed, 28 Sep 2016 02:33:39 +0530 <![CDATA[Live Stock Market Updates - Sensex ends 71 points down]]> http://www.indiainfoline.com/article/news-top-story/live-stock-market-updates-today-nifty-sensex-bse-nse-116092700300_1.html Wed, 28 Sep 2016 02:33:39 +0530 <![CDATA[Amgen Announces TopLine Results From Phase 3 KYPROLIS Carfilzomib CLARION Study In Newly Diagnosed Multiple Myeloma Patients]]> https://www.pharmafocusasia.com/pressreleases/amgen-announces-top-line-results-from-phase-3-kyprolis-carfilzomib-clarion-study-in-newly-diagnosed-multiple-myeloma-patients Wed, 28 Sep 2016 02:33:39 +0530